JNCE - Jounce Therapeutics Inc
Close
1.88
-0.050 -2.660%
Share volume: 0
Last Updated: Wed 03 May 2023 10:00:00 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$1.93
-0.05
-2.59%
Summary score
31%
Profitability
25%
Dept financing
33%
Liquidity
48%
Performance
31%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-3.78%
Return on assets
-1.83%
Return on sales
0%
Return on invested capital
3.34%
Total debt ratio
43.85%
Debt ratio change over timeo
4.59%
Current Ratio
5.22%
Quick Ratio
0%
Cash Position Ratio
1.74%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-0.16%
Return on assets
-0.02%
Return on sales
0%
Return on invested capital
-46.28%
Total debt ratio
16.41%
Debt ratio change over timeo
-0.83%
Current Ratio
11.09%
Quick Ratio
0%
Cash Position Ratio
4.62%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-21.98%
Return on assets
-17.78%
Return on sales
0%
Return on invested capital
-248.52%
Total debt ratio
19.91%
Debt ratio change over time
-1.12%
Current Ratio
8.04%
Quick Ratio
0%
Cash Position Ratio
4.56%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-106.91%
Return on assets
-94.43%
Return on sales
0%
Return on invested capital
129.79%
Total debt ratio
458.79%
Debt ratio change over time
4.59%
Current Ratio
35.85%
Quick Ratio
0%
Cash Position Ratio
8.38%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | JNCE | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -3.78% | -4.61% | -11.83% | 0% |
| Return on assets | -1.83% | -4.6% | -10.3% | 0% |
| Return on sales | 0% | -37.29% | 0% | 0% |
| Return on invested capital | 3.34% | 265.33% | -27.14% | 0% |
| Profitability | 25% | 25% | 0% | 50% |
| Total debt ratio | 43.85% | 18.22% | 14.3% | 0% |
| Debt ratio change over time | 4.59% | -1.66% | -1.56% | 0% |
| Dept financing | 50% | 10% | 8% | 0% |
| Current Ratio | 11.09% | 4.65% | 5.1% | 0% |
| Quick Ratio | 0% | 4.32% | 0% | 0% |
| Cash Position Ratio | 4.62% | 0.81% | 2.5% | 0% |
| Liquididy | 43% | 50% | 45% | 0% |
| Short-term ratios | JNCE | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -0.16% | -3.62% | -13.55% | 0% |
| Return on assets | -0.02% | -3.93% | -11.56% | 0% |
| Return on sales | 0% | -34.27% | 0% | 0% |
| Return on invested capital | -46.28% | -9.88% | -24.84% | 0% |
| Profitability | 25% | 0% | 0% | 75% |
| Total debt ratio | 16.41% | 15.47% | 15.89% | 0% |
| Debt ratio change over time | -0.83% | -0.59% | -1.72% | 0% |
| Dept financing | 25% | 24% | 24% | 25% |
| Current Ratio | 11.09% | 4.65% | 5.1% | 0% |
| Quick Ratio | 0% | 4.32% | 0% | 0% |
| Cash Position Ratio | 4.62% | 0.81% | 2.5% | 0% |
| Liquididy | 50% | 40% | 25% | 0% |